Member Info for Bladderman

Hahahah. Brilliant.

June on Monday - need we say more...!!

Mind, nice positive reaction at the end which looks more healthy from a TA perspective.

Spot on Plantpower. The fundamentals are very strong here and we have £8-£10M cash. Excellent

4.3M traded even on a down day on the markets.

Massive volume again expected Monday.

All he cares about is his short. Which contradicts his shortsburnrsburn name. Grade A ******.

The product has been available for a week. Why would we take until July for news lol. Also why do you think 6-8 weeks for a key product in demand from the FDA. EU approval was three weeks. Why not knock on the door at AVCT or ODX and question their position as ODX have no validated product presently. Careful of agendas here. Especially this guy who openly stated he has a short open. Joker

Yes all very convenient if the Chinese have developed one. Also vaccines usually take years to develop with testing and validation. Fast tracking is highly dubious.

Besides, we're all about active COVID testing. Interesting last hour! June trading starts Monday! Lots of PR and time for people to do some listening and research. GDR is the real deal capable of producing 10,000 pellet tests an hour.

This share is like AVCT at 58-60p. Now 200p. Feet up time as GDR valuation is going through the roof in June

A very reassuring video for all holders. Massive week here next week. No doubt about it

Perspective:
#NCYT £213m mcap
#AVCT £384m mcap
#ODX £105m mcap
#TILS. £174m mcap

GDR valued at £77m with commercial sales in June

Add to the fact that the 96 well PCR are plates are universal and can be used in any diagnostics lab, i.e. no or very limited brand restriction. Move over NYCT

The US will love this 'superior' product. Less legal issues to address with false positives using a premixed freeze dried pellet

Hammering out a new base.

When news flow starts landing here just think.

Alone FDA fast track approval will lift this 50% +

200p should be breached first thing Monday which is only £90M and makes a mockery of other COVID stocks considering our position. We have some serious catching up to do

The biggest difference between this and ODX is there interview was hypothetical and the numbers were wrong. Here we have a market ready EU approved robust superior product. We are miles ahead of This is going to be massive

And the message is getting out there. Sales in June which starts Monday.

Massive discount

Nonetheless L2 just majorly flipped. What do these sense.

Better

This novel product is going to be massive. Global distribution being executed as we speak.